Argatroban Injection — Class I drug recall D-0082-2027
Ongoing recall by Par Health USA, LLC, reported 2026-10-28, distributed nationwide. Particulate matter: particulate matter identified as cellulose, polystyrene, polyethylene teraphalate, stainle
| Recall number | D-0082-2027 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Par Health USA, LLC, Rochester, MI, United States |
| Recall initiated | 2026-10-13 |
| Classified | 2026-10-26 |
| Reported by FDA | 2026-10-28 |
| Distributed | Nationwide (US) |
| Quantity | 18,991 vials |
| Reason classes | specification failure |
| NDC | 42023-0182, 42023-0182-01 |
| Lot numbers | 82682, 83449, 86714, 87302, 87560, 87753, 88401, 88614, 88836, 90220, 91216, 91219, 92004, 92006, 92009, 92596, 92782, 93107, 93329, 93890 |
| Expiration dates | 2026-10, 2026-11, 2027-02, 2027-03, 2027-04, 2027-05, 2027-06, 2027-07, 2027-08, 2027-09 |
Product
Argatroban Injection, USP, 250 mg/2.5mL (100 mg/mL), 2.5 mL x 1 Single Dose Vial, Rx only, Manufactured for: Endo USA, Malvern,PA 19355/Argatroban Injection, 250 mg/2.5mL (100 mg/mL), 2.5 mL x 1 Single Dose Vial, Rx only, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC 42023-182-01.
Reason for recall
Particulate matter: particulate matter identified as cellulose, polystyrene, polyethylene teraphalate, stainless steel, or stopper material in the product solution.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0082-2027. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-11-03. Not affiliated with or endorsed by FDA. Not medical or legal advice.